ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.411,55
-0,27%
S&P 500
5.321,41
0,25%
US Dollar vs BRL
5,1233
0,37%
Bitcoin
70.136,23
0,01%
Brent Oil
82,51
0,08%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Alpine Immune Sciences Inc (ALPN)

  7. Alpine Immune Sciences Inc (ALPN) Notícias

ALPN

Alpine Immune Sciences (ALPN)

Alpine Immune Sciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALPN
DataHoraFonteTítuloCódigoCompanhia
21/05/202417:49Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ALPNAlpine Immune Sciences Inc
20/05/202421:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALPNAlpine Immune Sciences Inc
20/05/202409:53Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ALPNAlpine Immune Sciences Inc
20/05/202409:42Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ALPNAlpine Immune Sciences Inc
20/05/202409:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALPNAlpine Immune Sciences Inc
20/05/202409:27Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:ALPNAlpine Immune Sciences Inc
09/05/202417:22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALPNAlpine Immune Sciences Inc
09/05/202417:00Business WireAlpine Immune Sciences Reports First Quarter 2024 Financial ResultsNASDAQ:ALPNAlpine Immune Sciences Inc
11/04/202417:27PR Newswire (US)Kuehn Law Encourages ALPN, JBT, ELYM, and HRT Investors to Contact Law FirmNASDAQ:ALPNAlpine Immune Sciences Inc
11/04/202408:24IH Market NewsCostco Increases Dividend by 14%, Meta Introduces ‘Artemis’ AI Chip, and More NewsNASDAQ:ALPNAlpine Immune Sciences Inc
10/04/202417:15Business WireAlpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA NephropathyNASDAQ:ALPNAlpine Immune Sciences Inc
10/04/202417:01Business WireVertex Enters Into Agreement to Acquire Alpine Immune SciencesNASDAQ:ALPNAlpine Immune Sciences Inc
01/04/202410:00Business WireAlpine Immune Sciences to Present Updated Clinical Data for Povetacicept in IgA Nephropathy at the World Congress of Nephrology 2024NASDAQ:ALPNAlpine Immune Sciences Inc
21/03/202408:45Business WireAlpine Immune Sciences Presents New Translational Data on Povetacicept at the European Lupus Meeting 2024NASDAQ:ALPNAlpine Immune Sciences Inc
20/03/202417:30Business WireAlpine Immune Sciences to Participate in Upcoming H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual ConferenceNASDAQ:ALPNAlpine Immune Sciences Inc
18/03/202417:05Business WireAlpine Immune Sciences Provides Corporate Update and Full Year 2023 Financial ResultsNASDAQ:ALPNAlpine Immune Sciences Inc
07/03/202418:30Business WireAlpine Immune Sciences to Report Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:ALPNAlpine Immune Sciences Inc
26/02/202418:30Business WireAlpine Immune Sciences to Participate in Two Upcoming Healthcare ConferencesNASDAQ:ALPNAlpine Immune Sciences Inc
14/02/202418:43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALPNAlpine Immune Sciences Inc
21/12/202318:15Business WireAlpine Immune Sciences Announces Amendment of Acazicolcept Option and License Agreement with AbbVieNASDAQ:ALPNAlpine Immune Sciences Inc
18/12/202318:30Business WireAlpine Immune Sciences to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ALPNAlpine Immune Sciences Inc
20/11/202318:30Business WireAlpine Immune Sciences to Participate in the Evercore ISI HealthconX ConferenceNASDAQ:ALPNAlpine Immune Sciences Inc
15/11/202311:00Business WireAlpine Immune Sciences Presents New Translational Data on Povetacicept in Systemic Lupus Erythematosus at American College of Rheumatology Convergence 2023NASDAQ:ALPNAlpine Immune Sciences Inc
14/11/202318:15Business WireAlpine Immune Sciences Reports Third Quarter 2023 Financial ResultsNASDAQ:ALPNAlpine Immune Sciences Inc
13/11/202311:00Business WireAlpine Immune Sciences Presents New Translational Data on Acazicolcept in Systemic Lupus Erythematosus at American College of Rheumatology Convergence 2023NASDAQ:ALPNAlpine Immune Sciences Inc
06/11/202323:41Business WireAlpine Immune Sciences Announces Pricing of $150 Million Public OfferingNASDAQ:ALPNAlpine Immune Sciences Inc
06/11/202323:37Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:ALPNAlpine Immune Sciences Inc
06/11/202308:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ALPNAlpine Immune Sciences Inc
06/11/202308:00Business WireAlpine Immune Sciences Announces Proposed Public OfferingNASDAQ:ALPNAlpine Immune Sciences Inc
03/11/202310:00Business WireAlpine Immune Sciences Presents New Preclinical Data on Povetacicept in Myasthenia Gravis at the American Association of Neuromuscular & Electrodiagnostic Medicine 2023 Annual MeetingNASDAQ:ALPNAlpine Immune Sciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALPN

Seu Histórico Recente

COIN
XRPBTC
Ripple
COIN
LTCUSD
Litecoin
NYSE
RIO
Rio Tinto
BOV
BBAS3
BANCO DO BRASIL ON
EU
PX1
CAC 40
COIN
ETHUSD
Ethereum
BOV
IBOV
Índice Bovespa
COIN
DASHUSD
Dash
NYSE
GGB
Gerdau
BOV
ELET6
ELETROBRAS PNB
BOV
BBDC4
BRADESCO PN
BOV
USIM5
USIMINAS PNA
BOV
B3SA3
B3 SA - Brasil Bolsa Bal... ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados